THQM — Tchaikapharma High Quality Medicines AD Share Price
0.000.00%
Last trade - 00:00- BGN1.47bn
- BGN1.48bn
- BGN48.55m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 13.95 | ||
| Price to Tang. Book | 14.43 | ||
| Price to Free Cashflow | 513.55 | ||
| Price to Sales | 30.29 | ||
| EV to EBITDA | 206.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.07% | ||
| Return on Equity | 3.72% | ||
| Operating Margin | 9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | BGNm | 34.72 | 40.39 | 42.55 | 43.15 | 48.55 | n/a | n/a | 4.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -78.75 | -55.41 | +66.32 | +45.35 | +40.29 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tchaikapharma High Quality Medicines AD is a Bulgaria-based company engaged in the generic pharmaceuticals industry. The Company specializes in manufacture of both generic and in-licensed medicines destined for alimentary tract and metabolism and antiinfectitives for systemic use, as well as cardiovascular, musculoskeletal, nervous and other systems. It also offers solutions for injection and vitamins and nutritional supplements.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- March 14th, 2000
- Public Since
- May 21st, 2015
- No. of Employees
- 191
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bulgarian Stock Exchange
- Shares in Issue
- 84,500,000
- Address
- Bul G. M. Dimitrov 1, SOFIA, 1172
- Web
- https://tchaikapharma.com/
- Phone
- +359 29625454
- Auditors
- ECOVIS AUDIT BG LTD
Upcoming Events for THQM
Similar to THQM
Sopharma Trading AD
Bulgarian Stock Exchange
FAQ
What is the Tchaikapharma High Quality Medicines AD share price?
As of Today at 19:21 UTC, shares in Tchaikapharma High Quality Medicines AD are trading at BGN17.40. This share price information is delayed by 15 minutes.
How has the Tchaikapharma High Quality Medicines AD share price performed this year?
Shares in Tchaikapharma High Quality Medicines AD last closed at BGN17.40 and the price had moved by +10.15% over the past 365 days. In terms of relative price strength the Tchaikapharma High Quality Medicines AD share price has outperformed the FTSE Global All Cap Index by +3.41% over the past year.
What are the analyst and broker recommendations for Tchaikapharma High Quality Medicines AD?
There is no consensus recommendation for this security.
What is the Tchaikapharma High Quality Medicines AD dividend yield?
Tchaikapharma High Quality Medicines AD does not currently pay a dividend.
Does Tchaikapharma High Quality Medicines AD pay a dividend?
Tchaikapharma High Quality Medicines AD does not currently pay a dividend.
When does Tchaikapharma High Quality Medicines AD next pay dividends?
Tchaikapharma High Quality Medicines AD does not currently pay a dividend.
How do I buy Tchaikapharma High Quality Medicines AD shares?
To buy shares in Tchaikapharma High Quality Medicines AD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Tchaikapharma High Quality Medicines AD?
As of the previous close price of BGN17.40, shares in Tchaikapharma High Quality Medicines AD had a market capitalisation of BGN1.47bn.
Where are Tchaikapharma High Quality Medicines AD shares listed?
Here are the trading details for Tchaikapharma High Quality Medicines AD:
- Country of listing: Bulgaria
- Exchange: BLG
- Ticker Symbol: THQM
What kind of share is Tchaikapharma High Quality Medicines AD?
Based on an overall assessment of its quality, value and momentum Tchaikapharma High Quality Medicines AD is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Tchaikapharma High Quality Medicines AD share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Tchaikapharma High Quality Medicines AD share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tchaikapharma High Quality Medicines AD. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -11.49%.
As of the last closing price of BGN17.40, shares in Tchaikapharma High Quality Medicines AD were trading +10.57% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Tchaikapharma High Quality Medicines AD PE Ratio?
The Tchaikapharma High Quality Medicines AD PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at BGN17.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Tchaikapharma High Quality Medicines AD?
We do not have data on Tchaikapharma High Quality Medicines AD's directors